The Need for More Effective Methods of Nonclinical Screening in Cancer Treatment-Related Cardiotoxicities
There are numerous in vivo, in vitro, and in silico models that can be used for both nonclinical testing of CV toxicities and follow-up investigations of underlying mechanisms, which can be used to develop cardioprotective therapies. IND = investigational new drug; NDA = new drug application.